carbostyril has been researched along with Liver Dysfunction in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (50.00) | 18.2507 |
| 2000's | 2 (16.67) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Houwen, RHJ; Slae, M; van der Woerd, WL; Wilschanski, M | 1 |
| Bertolini, A; Bodewes, FAJA; Jonker, JW; van de Peppel, IP; Verkade, HJ | 1 |
| Chen, Y; Guo, B; Kang, Y; Li, Y; Wang, K; Wu, J; Xu, F; Yu, J; Zhang, J; Zhang, Y | 1 |
| Custodio, JM; Kearney, BP; Ling, KH; Ramanathan, S; Rhee, M; Shen, G | 1 |
| Boulton, DW; Bramer, SL; Mallikaarjun, S; Shoaf, SE | 1 |
| Bramer, SL; Kitani, M; Miyamoto, G; Tammara, B; Trang, JM | 1 |
| Hind, ID; Hinson, JL; Weidler, DJ | 1 |
| Kim, KH; Lee, SM | 1 |
| Akaike, T; Maeda, H; Niki, E; Nishigori, H; Urakami, T; Yoshida, C | 1 |
| Bass, N; Bramer, SL; Efthymiopoulos, C; Flaherty, JF; Maroli, A; Somberg, K; Wolfe, E | 1 |
| Iakovlev, VP | 1 |
| Kinzig, M; Mahr, G; Muth, P; Naber, KG; Sorgel, F | 1 |
4 review(s) available for carbostyril and Liver Dysfunction
| Article | Year |
|---|---|
Effects of new and emerging therapies on gastrointestinal outcomes in cystic fibrosis.
Topics: Aminophenols; Aminopyridines; Benzodioxoles; Body Mass Index; Chloride Channel Agonists; Cystic Fibrosis; Digestive System; Drug Combinations; Gastroesophageal Reflux; Humans; Hydrogen-Ion Concentration; Intestinal Diseases; Liver Diseases; Probiotics; Quinolones; Treatment Outcome; Weight Gain | 2017 |
Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.
Topics: Aftercare; Aminophenols; Aminopyridines; Benzodioxoles; Chloride Channel Agonists; Cholagogues and Choleretics; Cystic Fibrosis; Drug Combinations; Elasticity Imaging Techniques; Humans; Liver Diseases; Liver Transplantation; Quinolones; Ursodeoxycholic Acid | 2017 |
[Comparative pharmacokinetics of lomefloxacin and other fluoroquinolones].
Topics: Age Factors; Anti-Infective Agents; Area Under Curve; Creatinine; Drug Interactions; Fluoroquinolones; Humans; Intestinal Absorption; Liver Diseases; Quinolones; Renal Insufficiency; Tissue Distribution | 1998 |
Comparative pharmacokinetics of ciprofloxacin and temafloxacin in humans: a review.
Topics: Aging; Anti-Infective Agents; Ciprofloxacin; Drug Interactions; Fluoroquinolones; Humans; Kidney Diseases; Liver Diseases; Quinolones; Tissue Distribution | 1991 |
6 trial(s) available for carbostyril and Liver Dysfunction
| Article | Year |
|---|---|
Population Pharmacokinetics Study of Nemonoxacin Among Chinese Patients With Moderate Hepatic Impairment.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Asian People; Female; Humans; Linear Models; Liver Diseases; Male; Middle Aged; Models, Biological; Quinolones | 2019 |
Pharmacokinetics and safety of boosted elvitegravir in subjects with hepatic impairment.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; Female; Humans; Liver Diseases; Male; Middle Aged; Quinolones; Young Adult | 2014 |
Effects of hepatic or renal impairment on the pharmacokinetics of aripiprazole.
Topics: Adult; Aged; Antipsychotic Agents; Area Under Curve; Aripiprazole; Female; Humans; Kidney Diseases; Liver Diseases; Male; Middle Aged; Piperazines; Protein Binding; Quinolones; Severity of Illness Index | 2008 |
The pharmacokinetics of toborinone in subjects with congestive heart failure and concomitant renal impairment and/or concomitant hepatic impairment.
Topics: Adult; Aged; Cardiotonic Agents; Chromatography, High Pressure Liquid; Female; Heart Failure; Humans; Indicators and Reagents; Infusions, Intravenous; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Function Tests; Male; Middle Aged; Quinolones; Reproducibility of Results; Time Factors | 2002 |
Pharmacokinetics, safety, and tolerability of flosequinan in patients with hepatic dysfunction.
Topics: Adult; Biotransformation; Chromatography, High Pressure Liquid; Female; Humans; Liver Diseases; Male; Middle Aged; Quinolines; Quinolones; Spectrophotometry, Ultraviolet | 1994 |
Grepafloxacin pharmacokinetics in individuals with hepatic dysfunction.
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Area Under Curve; Drug Monitoring; Female; Fluoroquinolones; Humans; Liver Diseases; Male; Middle Aged; Piperazines; Quinolones | 1997 |
2 other study(ies) available for carbostyril and Liver Dysfunction
| Article | Year |
|---|---|
Rebamipide ameliorates hepatic dysfunction induced by ischemia/reperfusion in rats.
Topics: Alanine; Alanine Transaminase; Allopurinol; Animals; Bile; Enzyme Inhibitors; Free Radical Scavengers; Lipid Peroxidation; Liver Diseases; Male; Microsomes, Liver; Mixed Function Oxygenases; NADPH-Ferrihemoprotein Reductase; Organ Size; Quinolones; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Vitamin E; Xanthine Oxidase | 1995 |
Synthesis of monoesters of pyrroloquinoline quinone and imidazopyrroloquinoline, and radical scavenging activities using electron spin resonance in vitro and pharmacological activity in vivo.
Topics: Administration, Oral; Animals; Biological Assay; Carbon Tetrachloride; Cataract; Chemical and Drug Induced Liver Injury; Chick Embryo; Coenzymes; Electron Spin Resonance Spectroscopy; Esters; Free Radical Scavengers; Free Radicals; Hydroxyl Radical; Injections, Intraperitoneal; Liver; Liver Diseases; Male; Mice; Mice, Inbred ICR; PQQ Cofactor; Quinolones; Quinones; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxides | 1997 |